Organisation paid for research Program year 2022 Source: CMS Open Payments

Ko Clinical Research LLC

Neither a doctor nor a teaching hospital

Research payments

$56,750

16 payments

Through program year 2022, Ko Clinical Research LLC is reported as receiving $56,750 in research payments, across 16 payments.

By program year

4 rows
Year Kind Amount Payments
2022 Research $4,485 3
2021 Research $44,290 9
2020 Research $3,125 3
2019 Research $4,850 1

Breakdown

Who paid Research payments · program years 2019–2022
  1. Myovant Sciences Inc. $40,450 7 payments
  2. Bayer HealthCare Pharmaceuticals Inc. $14,123 8 payments
  3. AbbVie, Inc. $2,178 1 payment
Studies the money was for Research payments · program years 2019–2022
  1. An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Administered With and Without Low Dose Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids $16,963 1 payment
  2. An International Phase 3 Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids $14,247 5 payments
  3. Liberty Extension: An International Phase 3 Open-Label, Single-Arm, Long-Term Efficacy and Safety Extension Study to Evaluate Relugolix Co-Administered With Low-Dose Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids $9,240 1 payment
  4. BAY1002670 Long term Safety vs SoC $4,850 1 payment
  5. BAY1454032 Essure System for Permanent Birth Control $3,840 2 payments
  6. Bay1002670 Endometriosis Dose finding EU & US JP CN $3,125 3 payments
  7. BAY1454032, Essure System for Permanent Birth Control $2,308 2 payments
  8. Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women $2,178 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record